Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Weinberger

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Geroscience|September 16, 2023
Associations of circulating GDF15 with combined cognitive frailty and depression in older adults of the MARK-AGE studyBastian Kochlik, Catrin Herpich, María Moreno-Villanueva, et al.
Mechanisms of Ageing and Development|September 16, 2024
Development and validation of cardiometabolic risk predictive models based on LDL oxidation and candidate geromarkers from the MARK-AGE dataAndrei Valeanu, Denisa Margina, Daniela Weber, et al.
Biogerontology|July 30, 2025
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE populationLaura Cianfruglia, Carlo Fortunato, Gretta Veronica Badillo Pazmay, et al.
Mechanisms of Ageing and Development|March 2, 2025
Association of cytomegalovirus serostatus with ELOVL2 methylation: Implications for lipid metabolism, inflammation, DNA damage, and repair capacity in the MARK-AGE study populationRobertina Giacconi, Chiara Pirazzini, Maria Giulia Bacalini, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 24, 2024
Association Between TTV Viremia, Chronic Inflammation, and Ischemic Heart Disease Risk: Insights From MARK-AGE and Report-Age ProjectsRobertina Giacconi, Francesco Piacenza, Fabrizio Maggi, et al.
Gerontology|December 20, 2022
Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European CohortsRobertina Giacconi, Blanca Laffon, Solange Costa, et al.
Journal of Medical Virology|October 23, 2025
TTV Species Diversity as a Novel Biomarker of Immune Dysregulation in AgingFederica Novazzi, Pietro Giorgio Spezia, Francesca Drago Ferrante, et al.
Aging Cell|March 13, 2026
Biologically Younger Individuals, as Identified by MARK-AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of AgeMaría Moreno-Villanueva, Michael Junk, Grażyna Mosieniak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Geroscience|September 16, 2023
Associations of circulating GDF15 with combined cognitive frailty and depression in older adults of the MARK-AGE studyBastian Kochlik, Catrin Herpich, María Moreno-Villanueva, et al.
Mechanisms of Ageing and Development|September 16, 2024
Development and validation of cardiometabolic risk predictive models based on LDL oxidation and candidate geromarkers from the MARK-AGE dataAndrei Valeanu, Denisa Margina, Daniela Weber, et al.
Biogerontology|July 30, 2025
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE populationLaura Cianfruglia, Carlo Fortunato, Gretta Veronica Badillo Pazmay, et al.
Mechanisms of Ageing and Development|March 2, 2025
Association of cytomegalovirus serostatus with ELOVL2 methylation: Implications for lipid metabolism, inflammation, DNA damage, and repair capacity in the MARK-AGE study populationRobertina Giacconi, Chiara Pirazzini, Maria Giulia Bacalini, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Causal Inference Approaches Reveal Associations Between LDL Oxidation, NO Metabolism, Telomere Length and DNA Integrity Within the MARK-AGE StudyAndrei Valeanu, Denisa Margina, María Moreno-Villanueva, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 24, 2024
Association Between TTV Viremia, Chronic Inflammation, and Ischemic Heart Disease Risk: Insights From MARK-AGE and Report-Age ProjectsRobertina Giacconi, Francesco Piacenza, Fabrizio Maggi, et al.
Gerontology|December 20, 2022
Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European CohortsRobertina Giacconi, Blanca Laffon, Solange Costa, et al.
Journal of Medical Virology|October 23, 2025
TTV Species Diversity as a Novel Biomarker of Immune Dysregulation in AgingFederica Novazzi, Pietro Giorgio Spezia, Francesca Drago Ferrante, et al.
Aging Cell|March 13, 2026
Biologically Younger Individuals, as Identified by MARK-AGE Biological Age Scores, Display a Distinct Favourable Blood Chemistry Profile Regardless of AgeMaría Moreno-Villanueva, Michael Junk, Grażyna Mosieniak, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus StatementEmma Short, Ian M Adcock, Bilal Al-Sarireh, et al.
Pageof 7